Weisshorn Re AG appoints Patrick Kelleher as CEO
– SWITZERLAND, Zurich – Weisshorn Re AG announced today that it has elected Patrick Kelleher to the position of Chief Executive Officer and Delegate to the Board of Directors.…
– SWITZERLAND, Zurich – Weisshorn Re AG announced today that it has elected Patrick Kelleher to the position of Chief Executive Officer and Delegate to the Board of Directors.…
– SWITZERLAND, Zurich – GetYourGuide, the world’s largest online platform for tours and activities, today announced a strategic $4.5 million Series A extension round led by Kees Koolen, former CEO of Booking.com,…
– SWITZERLAND, Geneva – ObsEva, a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women’s reproductive medicine, with a main focus on therapies for preterm labor, announced today new appointments to its Board of Directors and Scientific Advisory Board.…
– SWITZERLAND, Geneva – Calypso Biotech SA is a Swiss pharmaceutical company engaged in the discovery and development of monoclonal antibodies to treat severe autoimmune gastro-intestinal diseases.
– SWITZERLAND – Covagen today announced that the company has secured CHF 42 million in a tranched Series B financing with an option to obtain an additional CHF 14 million that would increase the total amount of the financing round to CHF 56 million.…